Will Lockwood

Scientist with a focus on lung cancer biology. Lax player and coach. Senior Scientist - BC Cancer, Professor - University of British Columbia.

[Will Lockwood @WWL_18]

Another new paper from the lab. Great collaboration with @MLadanyi lab investigating the mechanisms of resistance to TKIs in METex14 driven cancers. https://t.co/o2QDgPqV8o

[Will Lockwood @WWL_18]

New paper from PhD student Jana in the lab about an unexpected finding that has major implications in the fidelity of CRISPR screens! https://t.co/9pz6TMbnxp

[Will Lockwood @WWL_18]

New review from our group on the paradoxical role of increased ERK signalling as a vulnerability in cancer cells: https://t.co/teP4ujsulV

[Will Lockwood @WWL_18]

Mom L C C

[Will Lockwood @WWL_18]

@BurrardsJrLAX I can most definitely identify one person in this picture, even as a cartoon.

[Inside Lacrosse @Inside_Lacrosse]

As the high school approaches we are back with our @QCollarOfficial National High School Preseason Rankings!

@lvilleblacrosse takes the top spot in the first Top 2⃣5⃣ this spring. (via @dkaplan46)

🔗 https://t.co/qAKepcgxGQ

[Will Lockwood @WWL_18]

@DriveBC Will people currently on the road outside of hellsgate heading south be let through? Or do they need to turn around?

[JTO & JTO CRR @JTOonline]

.@IASLC’s BaTS Committee review spotlights key advances in NSCLC research and outlines future areas that could improve survival and lead to new curative options for advanced disease. https://t.co/fHr7JKEbWY

[Science in Vancouver @ScienceVancity]

This week, we profile an Oncogene publication by the Lockwood lab at @BCCancer!

"This study addresses one of the central challenges in #LungCancer treatment: why tumors often relapse despite initial responses to targeted therapies," says Dr. Lockwood.

🧐 https://t.co/yDcBEV7t4B

[Will Lockwood @WWL_18]

This work was funded by @SRC_CRS which provided the opportunity to get this project off the ground and opening new areas of investigation into targeting ILK to prevent drug resistance in lung cancer patients.

[Will Lockwood @WWL_18]

Latest from the lab in collaboration with the Bennewith and Dedhar labs @BCCancer and Ladanyi lab @MSKCancerCenter. Graduate student Rocky Shi demonstrates the importance of ILK in mediating tolerance to EGFR-targeted therapy in lung cancer. https://t.co/0pKKTqnhkO

[Will Lockwood @WWL_18]

@drmcaswell @ucl Awesome Debbie! Congrats!

[Will Lockwood @WWL_18]

@TransLink Why is the west coast express not moving?

[Scott Lincicome @scottlincicome]

https://t.co/4n3s66JlH5

[Will Lockwood @WWL_18]

I Used to Run the N.I.H. Here’s What Worries Me. https://t.co/esVHN4dfL7

[Will Lockwood @WWL_18]

New review from MSc student Sarah in the lab:

MET Activation in Lung Cancer and Response to Targeted Therapies https://t.co/6EJlUBVGh5 #mdpicancers via @Cancers_MDPI

[Stephen V Liu, MD @StephenVLiu]

Congratulations to the chairs of the @IASLC #HTTR24 meeting - fantastic faculty and content. Engaging. Amazing faculty list. Hope it becomes a regular occurrence! Amazing job by Drs. @WWL_18 @CespedesMontse @aliceb_phd and Kenichi Suda!

[Jennifer C. King, PhD @JenniferCKing]

I’m learning so much about lineage plasticity at #HTTR24 - this has been a fabulous session of advances in cancer biology! @triparnasen @AttardiLaura Eric Gardner @WWL_18 @TuomasTammela

[Will Lockwood @WWL_18]

@TeddyJenner @WLAShamrocks Very cool! Congrats and well deserved!